Peer review reports
From: Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer
Original Submission | ||
---|---|---|
14 Jun 2015 | Submitted | Original manuscript |
Author responded | Author comments | |
Reviewed | Reviewer Report | |
Reviewed | Reviewer Report | |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
Author responded | Author comments | |
Resubmission - Version 3 | ||
Submitted | Manuscript version 3 | |
Author responded | Author comments | |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
Publishing | ||
3 Nov 2015 | Editorially accepted | |
11 Nov 2015 | Article published | 10.1186/s12885-015-1900-y |